• Kyodo News

  • SHARE

The current ban against teens taking the influenza prescription drug Tamiflu should remain in place as long as the possible causal relationship between its use and abnormal behavior is unclear, according to researchers on a health ministry panel.

The panel’s view, which was agreed at a meeting Wednesday, will be reflected in a report to be submitted to the safety research committee of the Health, Labor and Welfare Ministry, which is expected to approve the continuation of the ban.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.

SUBSCRIBE NOW